![]() NBT Analytics NBT Analytics is a company that provides EEG (electroencephalography) analysis for clinical trials. | ![]() Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. | ![]() IntegraGen IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases. | |
Founding Date | Founding Date 2015 | Founding Date 2007 | Founding Date 2000 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Amsterdam, NL HQ | Locations Miami, US HQ Woburn, US | Locations Évry, FR HQ Cambridge, US |
Employees | Employees 1 | Employees 6,0967% increase | Employees 4420% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 1.1 b | Valuation ($) 3.8 m |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) €5m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $400.9m (FY, 2025) | Cost of goods €1.8m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $205.9m (FY, 2025) | Gross profit €3.5m (FY, 2025) |
Net income | Net income N/A | Net income ($225.7m) (FY, 2025) | Net income (€2.7m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 31m | Total funding raised $ 14.3m |

Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View company
IntegraGen is a biotechnology company developing molecular markers for central nervous system and metabolic diseases.
View company